Hi-tech Navy plans to have only BTech officers

April 23, 2012
HI_TECH

New Delhi, April 23: Slowly but surely emerging as a powerful three-dimensional "blue-water'' force to protect India's geo-strategic interests stretching from Hormuz Strait to Malacca Strait, the Navy is now also focusing on creating high-tech "sea warriors''.

The force, in fact, is steaming ahead with plans to ensure all its new officers have BTech degrees because of the unprecedented expansion in warship technology. "The advanced platforms we are inducting, with their state-of-art weapons and other systems, will require all officers to have cutting-edge technical knowledge,'' said Navy's assistant chief of personnel (HRD) Rear Admiral P Ajit Kumar.

"We already have a large number of MTechs, including in areas like nuclear technology. Moreover, we are also looking to send eight officers abroad every year for MTechs in niche areas. Our training pattern is in line with where the First World navies are headed,'' he added.

Navy's ongoing warship, submarine and maritime aircraft acquisition programmes as well as proposed projects in the pipeline will together cost well over Rs 3,00,000 crore over the next 15 years, as was first reported by TOI earlier.

With the "maritime capability perspective plan for 2012-2027'' pegging the number of major warships required at about 150, there are already 44 warships and six submarines on order. Moreover, contracts for another 45 warships, including six new submarines and seven stealth frigates, are in the pipeline.

All this will require a strong sea-warrior cadre. "The government has given us lot of manpower sanctions. We have to step up inductions as well as ensure quality manpower comes in,'' said Rear Admiral Kumar.

In tune with this, the first direct-entry batch of 70 BTech officers will pass out of the Indian Naval Academy (INA) at Ezhimala (Kerala) in June 2013. Plans are also afoot to get the existing BSc degree curriculum converted to a BTech one for naval cadets at the tri-Service National Defence Academy (NDA) in Kadakwasla (Pune).

"Naval cadets, who come to INA for their 7th and 8th semesters after passing out from NDA, get MSc (Tech) degrees as of now. But they will also get BTech degrees in the near future,'' he added.

Concurrently, INA is also set for a major expansion at a cost of around Rs 340 crore. From an existing annual capacity of 750 trainees, INA will begin training 1,200 cadets from 2015 onwards. Similarly, the "annual training load'' at INS Chilka will be enhanced to well over 4,500 sailors.

Overall, Navy plans to take the strength of its officer cadre from the existing 8,200 to over 11,000. Similarly, the number of sailors will be enhanced from the current 48,000 to over 60,000 by 2015 or so.

To cater for this, the Navy is also upgrading its selection infrastructure. There are plans for a new selection center at Vizag, with three SSBs (services selection boards), to add to the ones at Bhopal, Bangalore and Coimbatore. There will also be an additional SSB at Diamond Harbour at Kolkata by mid-2013.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 21,2020

Kolkata, May 21: Around 300 nurses have left Kolkata for Manipur after resigning from their jobs, said JS Joyrita, Deputy Residence Commissioner, Manipur Bhavan, Kolkata on Wednesday.

"Around 60 more nurses will be leaving tomorrow. We are getting many calls from people who want to go back to Manipur," she said.

Earlier, it was reported that 185 nurses have quit their job from hospitals in Kolkata and returned to Imphal. Cristella, a nurse said: "We are not happy that we left our duties. But we faced discrimination, racism and people sometimes spit on us. Lack of PPE kits, and people used to question us everywhere we went."

According to the latest information available on the website of the Ministry of Health and Family Welfare, 2961 cases of the virus have been reported from West Bengal 1074 cured/migrated/discharged and 250 deaths.

India's COVID-19 tally reached 1,06,750 on Wednesday, according to the Union Ministry of Health and Family Welfare. As many as 140 deaths have been reported in the last 24 hours, taking the total number of deaths to 3,303. Out of the total cases, 61,149 are actives cases and 42,298 patients have been cured/discharged/migrated.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 29,2020

Bengaluru, May 29: Former prime minister H D Deve Gowda mourned the demise of Rajya Sabha member and Managing Director of leading Malayalam daily Mathrubhumi M P Veerendra Kumar, hailing him as a great journalist and writer.

"My deepest condolences on the demise of former union Minister and Rajya sabha member Shri M.P. Veerendra Kumar. He was a great journalist and writer. May god give strength to his family & his people to bear the loss," Gowda said in his condolence message.

Veerandra Kumar, who was a member of PTIs Board of Directors, died late Thursday at a private hospital in Kozhikode in Kerala following cardiac arrest.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.